Status of Cancer Survivorship Care: Should We Not Improve?

IF 0.3 Q3 MEDICINE, GENERAL & INTERNAL Ibnosina Journal of Medicine and Biomedical Sciences Pub Date : 2022-07-14 DOI:10.1055/s-0042-1755131
R. A. Singarachari
{"title":"Status of Cancer Survivorship Care: Should We Not Improve?","authors":"R. A. Singarachari","doi":"10.1055/s-0042-1755131","DOIUrl":null,"url":null,"abstract":"Cancer mortality has significantly decreased due to screening, early detection, improved diagnostics, treatments, and supportive care.1 Worldwide, an estimated 28.4 million new cancer cases are projected to occur in 2040.2 Cancer survival in the United Kingdom has doubled in the past 40 years from 24 to 50%.3 By 2040, we expect around 26 million cancer survivors in the United States of America.4 The total global cancer survivor population, including Asia, could be over several million. Undoubtedly, every healthcare provider will encounter a cancer survivor in their practice. The care of cancer survivors is often uncoordinated, incomplete, and tends to be fragmentary. Significant improvements in cancer survivor care are necessary in most parts of the developing world by implementing the core essentials of cancer survivorship care, such as ASCO, ESMO, National Academies of Sciences, Engineering and Medicine, and National Cancer Survivorship Resource Center (The Survivorship Center).5–7 We summarize this topic through a set of questions and answers. The core essentials of cancer survivorship care will be outlined, and finally, we will discuss a few methods of its implementation in our region.","PeriodicalId":13067,"journal":{"name":"Ibnosina Journal of Medicine and Biomedical Sciences","volume":" ","pages":""},"PeriodicalIF":0.3000,"publicationDate":"2022-07-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Ibnosina Journal of Medicine and Biomedical Sciences","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1055/s-0042-1755131","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"MEDICINE, GENERAL & INTERNAL","Score":null,"Total":0}
引用次数: 0

Abstract

Cancer mortality has significantly decreased due to screening, early detection, improved diagnostics, treatments, and supportive care.1 Worldwide, an estimated 28.4 million new cancer cases are projected to occur in 2040.2 Cancer survival in the United Kingdom has doubled in the past 40 years from 24 to 50%.3 By 2040, we expect around 26 million cancer survivors in the United States of America.4 The total global cancer survivor population, including Asia, could be over several million. Undoubtedly, every healthcare provider will encounter a cancer survivor in their practice. The care of cancer survivors is often uncoordinated, incomplete, and tends to be fragmentary. Significant improvements in cancer survivor care are necessary in most parts of the developing world by implementing the core essentials of cancer survivorship care, such as ASCO, ESMO, National Academies of Sciences, Engineering and Medicine, and National Cancer Survivorship Resource Center (The Survivorship Center).5–7 We summarize this topic through a set of questions and answers. The core essentials of cancer survivorship care will be outlined, and finally, we will discuss a few methods of its implementation in our region.
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
癌症幸存者护理的现状:我们不应该改进吗?
由于筛查、早期检测、改进诊断、治疗和支持性护理,癌症死亡率显著下降。1据估计,2042年全球将出现2840万例新的癌症病例。2过去40年,英国癌症生存率翻了一番,从24%增至50%。3到2040年,我们预计美国约有2600万癌症幸存者。4包括亚洲在内的全球癌症幸存者总数可能超过数百万。毫无疑问,每个医疗保健提供者在实践中都会遇到一位癌症幸存者。癌症幸存者的护理往往不协调、不完整,而且往往是零散的。通过实施癌症幸存者护理的核心要素,如ASCO、ESMO、美国国家科学院、工程院和医学院以及国家癌症幸存者资源中心(幸存者中心),大多数发展中国家都有必要显着改善癌症幸存者护理。将概述癌症生存护理的核心要点,最后,我们将讨论在我们地区实施该护理的几种方法。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
自引率
50.00%
发文量
18
期刊最新文献
Academic Medical Career versus Private Medical Practice: A Guide to the Right Decision! Expecting the Unexpected: Schistosomial Appendicitis in Nonendemic Area Causes of Original Kidney Disease among Libyan Kidney Transplant Recipients IJMBS at the End of 2023: An Impact Factor and a New Platform Management of Sigmoid Volvulus: A Literature Review
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1